Literature DB >> 24798944

Erlotinib might be a double-edged sword in HCC.

Jin-Zhong Dong1, Li-Ping Wang, Sai-Nan Zhang, Zhuo-Lin Zou, Ming-Qin Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24798944     DOI： 10.1002/hep.27205

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Authors:  Shukun Zhang; Wenmin Ge; Gangyong Zou; Lin Yu; Yongcun Zhu; Qiujing Li; Yujie Zhang; Zhanli Wang; Tao Xu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

2.  β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development.

Authors:  Yue-Ming Ling; Jin-Yu Chen; Libin Guo; Chen-Yi Wang; Wen-Ting Tan; Qing Wen; Shu-Dong Zhang; Guo-Hong Deng; Yao Lin; Hang Fai Kwok
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.